(19)
(11) EP 2 451 284 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
24.05.2017 Bulletin 2017/21

(45) Mention of the grant of the patent:
29.03.2017 Bulletin 2017/13

(21) Application number: 10797874.4

(22) Date of filing: 08.07.2010
(51) International Patent Classification (IPC): 
A61K 9/10(2006.01)
A61K 9/14(2006.01)
C30B 7/12(2006.01)
B82Y 30/00(2011.01)
A61K 33/24(2006.01)
A61K 9/00(2006.01)
C30B 29/02(2006.01)
B22F 1/00(2006.01)
(86) International application number:
PCT/US2010/041427
(87) International publication number:
WO 2011/006007 (13.01.2011 Gazette 2011/02)

(54)

NOVEL GOLD-BASED NANOCRYSTALS FOR MEDICAL TREATMENTS AND ELECTROCHEMICAL MANUFACTURING PROCESSES THEREFOR

NEUE NANOKRISTALLE AUF GOLDBASIS FÜR MEDIZINISCHE BEHANDLUNG UND ELEKTROCHEMISCHE HERSTELLUNGSVERFAHREN DAFÜR

NANOCRISTAUX À BASE D'OR INÉDITS UTILISABLES DANS LE CADRE DE TRAITEMENTS MÉDICAUX ET LEURS PROCÉDÉS ÉLECTROCHIMIQUES DE FABRICATION


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

(30) Priority: 08.07.2009 US 223944 P
16.07.2009 US 226153 P
24.07.2009 US 228250 P
20.08.2009 US 235574 P
08.10.2009 US 249804 P
23.11.2009 US 263648 P
13.01.2010 US 294690 P

(43) Date of publication of application:
16.05.2012 Bulletin 2012/20

(73) Proprietor: Clene Nanomedicine, Inc.
Havre de Grace, MD 21078 (US)

(72) Inventors:
  • MORTENSON, Mark
    North East Maryland 21901 (US)
  • PIERCE, D., Kyle
    Elkton Maryland 21921 (US)
  • BRYCE, David
    Maryland 21921 (US)
  • DORFMAN, Adam
    Baltimore Maryland 21230 (US)
  • WILCOX, Reed
    Littleton Colorado 80127 (US)
  • LOCKETT, Anthony
    Leeds LS16 5JE (GB)
  • MERZLIAKOV, Mikhail
    Parkville Maryland 21234 (US)

(74) Representative: Wilson, Peter David George 
Novagraaf UK Centrum Norwich Research Park Colney Lane
Norwich NR4 7UG
Norwich NR4 7UG (GB)


(56) References cited: : 
WO-A1-2010/083040
US-A1- 2006 068 026
US-A1- 2006 207 388
US-A1- 2007 140 966
US-A1- 2009 169 807
WO-A2-2006/137851
US-A1- 2006 068 026
US-A1- 2006 207 388
US-A1- 2008 266 555
US-A1- 2009 169 807
   
  • WEIBO CAI ET AL: "Applications of gold nanoparticles in cancer nanotechnology", NANOTECHNOLOGY, SCIENCE AND APPLICATIONS, vol. 2008, 19 September 2008 (2008-09-19), pages 17-32, XP055092975, ISSN: 1177-8903
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).